4th Quarter - Report

WILLIAMS AND JENSEN, PLLC for PHRMA

Period 4th Quarter 2022 Filed Jan 20, 2023 Signed by TJ Hartten

Official filing
Firm
WILLIAMS AND JENSEN, PLLC
Client
PHRMA
Income
$50,000
Expenses
—

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 1435, H.R. 2873, H.R. 2884.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN COS, Rep. Van Hilleary and Majority Whip Tom DeLay
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. Cox
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2873 (117th), S. 1435 (117th), H.R. 2884 (117th)

Medical/Disease Research/Clinical Labs MED

Reauthorization of the Prescription Drug User Fee Act. H.R. 4511,FDA Advancing Collection of Transformative Science (FACTS Act).

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. Cox

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4511 (117th)

Medicare/Medicaid MMM

General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing proposal, Medicare Rebate Rule. Drug pricing legislation including H.R. 3, Medicare rebate reform, "buy America" proposals, and proposals to impose "most favored nation" pricing on Medicare Part B and D. Policies impacting U.S. address to the Covid-19 pandemic, including American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319. H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169). H.R. 3. H.R. 19. Provisions included in the Consolidated Appropriations Act, FY 23 (P.L. 117-328) related to the regulation of pharmaceuticals.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN COS, Rep. Van Hilleary and Majority Whip Tom DeLay
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. Cox
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1319 (117th), H.R. 5376 (117th), H.R. 19 (117th), H.R. 3 (117th)

Health Issues HCR

General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. CMMI Medicare Part B Demonstration. Drug pricing legislation including H.R. 3, Medicare rebate reform, "buy America" proposals, and proposals to impose "most favored nation" pricing on Medicare Part B and D. Policies impacting U.S. address to the Covid-19 pandemic, including American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319. H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169). H.R. 3. H.R. 19. H.R. 4511. Provisions included in the Consolidated Appropriations Act, FY 23 (P.L. 117-328) related to the regulation of pharmaceuticals.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN COS, Rep. Van Hilleary and Majority Whip Tom DeLay
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. Cox
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1319 (117th), H.R. 5376 (117th), H.R. 4511 (117th), H.R. 3 (117th), H.R. 19 (117th)

Budget/Appropriations BUD

Issues related to pharmaceutical development; Policies impacting Medicare Part D; Part B and 340 B programs; Policies impacting U.S. address to the Covid-19 pandemic, including American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319. Buy America procurement proposals. H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169). Provisions included in the Consolidated Appropriations Act, FY 23 (P.L. 117-328) related to the regulation of pharmaceuticals.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN COS, Rep. Van Hilleary and Majority Whip Tom DeLay
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER Shrd employee, Ofc of the Speaker & Ofc of VA 7; Sr Policy Adv, Maj Leader, Rep Cantor; Sr. Policy Adv, Republican Whip, Rep Cantor; Sr. Policy Adv, Maj Whip, Rep Roy Blunt; Prof Staff House Committee E&C; SR LA Rep Cox.
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1319 (117th), H.R. 5376 (117th)

Trade (domestic/foreign) TRD

IP Protections related to trade agreements; trade policies impacting pharmaceutical development. Legislative proposals related to WTO TRIPS Waiver.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN COS, Rep. Van Hilleary and Majority Whip Tom DeLay
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. Cox
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Defense DEF

Issues related to pharmaceutical manufacturing and development.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN COS, Rep. Van Hilleary and Majority Whip Tom DeLay
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. Cox
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Law Enforcement/Crime/Criminal Justice LAW

False Claims Amendments Act of 2021, S.2428.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN COS, Rep. Van Hilleary and Majority Whip Tom DeLay
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. Cox
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2428 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.